Cochlear Limited (ASX: COH)
Australia
· Delayed Price · Currency is AUD 293.02
-4.98 (-1.67%)
Nov 21, 2024, 4:10 PM AEST
Cochlear Revenue
In the fiscal year ending June 30, 2024, Cochlear had annual revenue of 2.24B AUD with 15.47% growth. Cochlear had revenue of 1.14B in the half year ending June 30, 2024, with 37.40% growth.
Revenue
2.24B
Revenue Growth
+15.47%
P/S Ratio
8.59
Revenue / Employee
442.96K
Employees
5,097
Market Cap
19.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 2.24B | 299.50M | 15.47% |
| Jun 30, 2023 | 1.94B | 287.80M | 17.46% |
| Jun 30, 2022 | 1.65B | 150.70M | 10.06% |
| Jun 30, 2021 | 1.50B | 177.00M | 13.40% |
| Jun 30, 2020 | 1.32B | -106.10M | -7.44% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 22.18B |
| ResMed Inc. | 6.93B |
| Pro Medicus Limited | 161.50M |
| Fisher & Paykel Healthcare Corporation Limited | 1.60B |
| Sonic Healthcare Limited | 8.97B |
| Ramsay Health Care Limited | 16.66B |
| Telix Pharmaceuticals Limited | 645.68M |
| Clarity Pharmaceuticals Ltd | 11.51M |
Cochlear News
- 8 days ago - MED-EL Corporation Announces FDA Approval of Expanded Candidacy Indications and Hearing Preservation Results for the MED-EL Cochlear Implant System - Business Wire
- 2 months ago - Cochlear Limited goes ex dividend tomorrow - Seeking Alpha
- 2 months ago - Healthy Aging Month | Daughter helps father win back his livelihood with cochlear implant - PRNewsWire
- 2 months ago - NMC to give ₹6L for each cochlear op - The Times of India
- 3 months ago - Cochlear Non-GAAP EPS of $5.90, revenue of $2.26B beats by $630M; initiates FY25 guidance - Seeking Alpha
- 3 months ago - Cochlear CEO: targeting 'around 10%' revenue growth per year over the very long term - CNBC
- 3 months ago - Cochlear Limited 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Cochlear Limited (CHEOF) Q4 2024 Earnings Call Transcript - Seeking Alpha